newsfilter
← Latest News
PR Newswire·

Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split

Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR) (the "Company"), a commercial-stage biopharmaceutical company focused on the development of innovative...